| |
The Product
- DAR No. 1 seeds, DAR No. 1 variety is of high output,
good quality, well adapting and anti-bugs. On July
2004, DAR No.1 was identified Superior by Sichuan Seeds
Station and Sichuan Variety Authentication Council.
DAR No. 1 seed distinguishes itself from ordinary seed
in many aspects.
- DAR Products: the root, DAR slice, DAR abstract
- DAR relative products using DAR abstract as the main
ingredient, such as, Bailing tablet.
The Root
Dahurian Angelica Root (DAR), the root
of an herb, Dahurian Angelica, which is widely used in
China, and considered to be an important ingredient Chinese
traditional medicine.
How It's Being Used
The root together with other Chinese herb
can be boiled with water to drink to serve as a cure
or further process into abstract to become an ingredient
of a pill.
How CHRI Has The Best Quality
CHRI participated the making of DAR standard,
Good Agriculture Product (GAP), a method used in European
Union for all its agricultural products and was recently
introduced into China. This allows our DAR growing to
be a leader in the business. CHRI has GAP certification.
Distinguish Between GAP DAR and Normal DAR
No. |
Ingredient |
QS of GAP
DAR |
Normal DAR |
1 |
Water |
≤12.0% |
N/A |
2 |
Ash |
≤6.0% |
N/A |
3 |
Insoluble Acid |
≤2.0% |
N/A |
4 |
Heavy Metal |
Lead |
≤5.0mg/kg |
N/A |
Cadmium |
≤0.3mg/kg |
N/A |
Mercury |
≤0.2mg/kg |
N/A |
Arsenic |
≤2.0mg/kg |
N/A |
5 |
Persticide Residue |
Benzene hexachloride
(BHC) |
≤2‰ |
N/A |
Gesarex |
≤2‰ |
N/A |
Terrachlor |
≤1‰ |
N/A |
6 |
Microbes |
Virus |
≤30000unit/g |
N/A |
Mucedine |
≤100 unit/g |
N/A |
Colibacillus |
N/A |
N/A |
7 |
Extract |
≥14.0% |
N/A |
8 |
Imperatorin & Alloisoimperatorin |
≥0.16% |
N/A |
9 |
Total Coumarin |
≥0.5% |
N/A |
What's more, Suining City , where CHRI's
DAR is grown has the good soil for DAR. The soil is nutritious,
rich in micronutrients especially Potassium and Phosphorus.
All The Different Applications
That The Root Has...
to cure pain, swelling and pustule, to
reduce itching. It has an aroma to awake the brain.
What Revenues Could Grow
To...
by the end of the 3 rd year, the revenue
will $130,000,000. Net profit will be $22,000,000
Acquisitions
CHRI signed merger letter of intent (LOI) with Sichuan
Zhufeng Medicine Co. ( a company with GMP certified factory).
It will give a boost to the accomplishment of the industrial
chain integration plan of CHRI by forming a GMP (Good
Manufacture Practice) pharmacy which is one of the three
parts of the industrial chain, for the merged Zhufeng
will become the production base of CHRI for DAR processed
products. Zhufeng Medicine Co. is a pharmacy with the
primary business of 20 types of biological medicines
production. It has a factory consistent with GMP criterion.
Its core product, Saffron Oil, is the first class medicine
in China . The output and revenue in 2006 was $ 8 million.
Growth Strategies
- to expand the growing area of GAP certified DAR
- to develop GMP(Good Manufacture Practice) certified
process factory
- to establish GSP( Good Supplying Practice) sales
chanel
By combining 1, 2 and 3, CHRI can become
very competitive in the industry, gain high added value
of DAR and take up a large percentage of market share |
|
